NM_002047.4:c.1219G>A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PP3_ModerateBS1_SupportingBS2
The NM_002047.4(GARS1):c.1219G>A(p.Gly407Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.1219G>A | p.Gly407Ser | missense_variant | Exon 10 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.1219G>A | p.Gly407Ser | missense_variant | Exon 10 of 17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.1117G>A | p.Gly373Ser | missense_variant | Exon 9 of 16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.1051G>A | p.Gly351Ser | missense_variant | Exon 11 of 18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.1018G>A | p.Gly340Ser | missense_variant | Exon 10 of 17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.850G>A | p.Gly284Ser | missense_variant | Exon 10 of 17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.850G>A | p.Gly284Ser | missense_variant | Exon 11 of 18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.1219G>A | non_coding_transcript_exon_variant | Exon 10 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*933G>A | non_coding_transcript_exon_variant | Exon 11 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*319G>A | non_coding_transcript_exon_variant | Exon 11 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*557G>A | non_coding_transcript_exon_variant | Exon 11 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.1219G>A | non_coding_transcript_exon_variant | Exon 10 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1089G>A | non_coding_transcript_exon_variant | Exon 11 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.1219G>A | non_coding_transcript_exon_variant | Exon 10 of 15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*1161G>A | non_coding_transcript_exon_variant | Exon 12 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*164G>A | non_coding_transcript_exon_variant | Exon 10 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*670G>A | non_coding_transcript_exon_variant | Exon 10 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*508G>A | non_coding_transcript_exon_variant | Exon 11 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*651G>A | non_coding_transcript_exon_variant | Exon 10 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.1219G>A | non_coding_transcript_exon_variant | Exon 10 of 16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000674616.1 | n.*933G>A | 3_prime_UTR_variant | Exon 11 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*319G>A | 3_prime_UTR_variant | Exon 11 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*557G>A | 3_prime_UTR_variant | Exon 11 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000675529.1 | n.*1089G>A | 3_prime_UTR_variant | Exon 11 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*1161G>A | 3_prime_UTR_variant | Exon 12 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*164G>A | 3_prime_UTR_variant | Exon 10 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*670G>A | 3_prime_UTR_variant | Exon 10 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*508G>A | 3_prime_UTR_variant | Exon 11 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*651G>A | 3_prime_UTR_variant | Exon 10 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249548Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135390
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461824Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727208
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.G407S variant (also known as c.1219G>A), located in coding exon 10 of the GARS gene, results from a G to A substitution at nucleotide position 1219. The glycine at codon 407 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 407 of the GARS protein (p.Gly407Ser). This variant is present in population databases (rs370650205, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with GARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 577910). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GARS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at